• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Pharmacotherapy: A Pathophysiologic Approach, Eighth Edition

Pharmacotherapy: A Pathophysiologic Approach, Eighth Edition

9780071703543
831,54 zł
789,96 zł Zniżka 41,58 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 789,96 zł
Ilość
Produkt niedostępny
Nakład wyczerpany (niedostępny u wydawcy)

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis

The most comprehensive, widely used, and evidence-based pharmacotherapy text available

Full-color design!

A Doodys Core Title ESSENTIAL PURCHASE for 2011!

5 STAR DOODYSS REVIEW!
This is a gold standard reference in pharmacy and the information it provides equips readers with the knowledge base and confidence to provide the highest quality of patient care.--Doodys Review Service

Hailed by Doodys Review Service as one of the best in pharmacy Pharmacotherapy:: A Pathophysiologic Approach is unmatched in its ability to help students develop a mastery of evidence-based medicine for optimum patient outcomes. The eighth edition will feature the addition of SI units throughout and an increased number of global examples and clinical questions.

Features

  • Unparalleled guidance in the development of pharmaceutical care plans
  • Full-color presentation
  • Key Concepts in each chapter
  • Critical Presentation boxes summarize common disease signs and symptoms
  • Clinical Controversies boxes examin complicated issues you face when providing drug therapy
  • NEW material added to the online learning center
  • EXPANDED evidence-based recommendations
  • EXPANDED coverage of timely issues such as palliative care and pain medicine
  • Therapeutic recommendations in each disease-specific chapter
Szczegóły produktu
49266
9780071703543
9780071703543

Opis

Rok wydania
2011
Numer wydania
8
Oprawa
twarda
Liczba stron
2700
Wymiary (mm)
224 x 285
Waga (g)
4350
  • Section 1:: Foundation IssuesSection Editor:: L. Michael Posey

    1.Pharmacoeconomics:: Principles, Methods, and Applications

    2.Health Outcomes and Quality of Life

    3.Health Literacy and Medication Use

    4.Cultural Competency

    5.Principles and Practices of Medication Safety

    6.Evidence Based Medicine

    7.Documentation of Pharmacy Services

    8.Clinical Pharmacokinetics and Pharmacodynamics

    9.Pharmacogenetics

    10.Pediatrics

    11.Geriatrics

    12.Palliative Care

    13. Pharmacoepidemiology

    14. Clinical Toxicology

    15. Emergency Preparedness:: Identification and Management of Biologic Exposures

    16. Emergency Preparedness:: Identification adn Management of Chemical and Radiologic Exposures

    Section 2:: Cardiovascular DisordersSection Editor:: Robert L. Talbert

    17.Cardiovascular Testing

    18.Cardiac Arrest

    19.Hypertension

    20.Systolic Heart Failure

    21.Diastolic Heart Failure and the Cardiomyopathies

    22.Acute Decompensated Heart

    23.Ischemic Heart DiseaseJ

    24.Acute Coronary Syndromes

    25.The Arrhythmias

    26. Venous Thromboembolism

    27.Stroke

    28.Dyslipidemia

    29.Peripheral Arterial Disease

    30.Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock

    31.Hypovolemic Shock

    Section 3:: Respiratory DisordersSection Editor:: Robert L. Talbert

    32.Introduction to Pulmonary Function Testing

    33.Asthma

    34.Chronic Obstructive Pulmonary Disease

    35.Pulmonary Hypertension

    36.Drug-Induced Pulmonary Diseases

    37.Cystic Fibrosis

    Section 4:: Gastrointestinal DisordersSection Editor:: Joseph T. DiPiro

    38.Evaluation of the Gastrointestinal Tract

    39.Gastroesophageal Reflux Disease

    40.Peptic Ulcer Disease

    41.Inflammatory Bowel Disease

    42.Nausea and Vomiting

    43.Diarrhea, Constipation, and Irritable Bowel Syndrome

    44.Portal Hypertension and Cirrhosis

    45.Drug-Induced Liver Disease

    46.Pancreatitis

    47.Viral Hepatitis

    48.Drug Therapy Individualization in Patients with Hepatic Disease or Genetic Alterations in Drug Metabolizing Activity

    49. Celiac Disease

    Section 5:: Renal DisordersSection Editor:: Gary R. Matzke

    50.Clinical Assessment of Kidney Function

    51.Acute Kidney Injury

    52.Chronic Kidney Disease:: Progression-Modifying Therapies

    53.Chronic Kidney Disease:: Management of Complications

    54.Hemodialysis and Peritoneal Dialysis

    55.Drug-Induced Kidney Disease

    56.Glomerulonephritis

    57.Drug Therapy Individualization for Patients with Renal Insufficiency

    58.Disorders of Sodium and Water Homeostasis

    59.Disorders of Calcium and Phosphorus Homeostasis

    60.Disorders of Potassium and Magnesium HomeostasisDonald F. Brophy and Todd W. B. Gehr

    61.Acid-Base Disorders

    Section 6:: Neurologic DisordersSection Editor:: Barbara G. Wells

    62.Evaluation of Neurologic Illness

    63.Alheimers Disease

    64. Multiple Sclerosis

    65. Epilepsy

    66.Status Epilepticus

    67.Acute Management of the Brain Injury Patient

    68.Parkinsons Disease

    69. Pain Management

    70.Headache Disorders

    Section 7:: Psychiatric DisordersSection Editor:: Barbara G. Wells

    71.Evaluation of Psychiatric Illness

    72.Childhood Disorders

    73.Eating Disorders

    74.Substance Related Disroders:: Overview and Depressahts, Stimulants and Hallucinogens

    75.Substance-Related Disorders:: Alcohol, Nicotine, and Caffeine

    76.Schizophrenia

    77.Major Depressive Disorders

    78.Bipolar Disorder

    79.Anxiety Disorders I:: Generalized Anxiety, Panic, and Social Anxiety Disorders

    80.Anxiety Disorders II:: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder

    81.Sleep Disorders

    82.Disorders Associated with Intellectual Disabilities

    83.Diabetes Mellitus

    84.Thyroid Disorders

    85.Adrenal Gland Disorders

    86.Pituitary Gland Disorders

    Section 9:: Gynecologic and Obstetric DisordersSection Editor:: Barbara G. Wells

    87.Pregnancy and Lactation:: Therapeutic Considerations

    88.Contraception

    89.Menstruation-Related Disorders

    90.Endometriosis

    91. Hormone Terapy in Women

    Section 10:: Urologic DisordersSection Editor:: L. Michael Posey

    92.Erectile Dysfunction

    93.Benign Prostatic Hyperplasia

    94.Urinary Incontinence

    Section 11:: Immunologic DisordersSection Editor:: Gary C. Yee

    95. Function and Evaluation of the Immune System

    96.Systemic Lupus Erythematosus and Other Collagen-Vascular Diseases

    97.Allergic and Pseudoallergic Drug Reactions

    98.Solid-Organ Transplantation

    Section 12:: Rheumatologic DisordersSection Editor:: L. Michael Posey

    99Osteoporosis and Other Metabolic Bone Diseases

    100.Rheumatoid Arthritis

    101.Osteoarthritis

    102. Gout and Hyperuricemia

    Section 13:: Ophthalmic and Otolaryngological DisordersSection Editor:: L. Michael Posey

    103.Glaucoma

    104.Allergic Rhinitis

    Section 14:: Dermatologic DisordersSection Editor:: L. Michael Posey

    105Dermatologic Drug Reactions and Common Skin Conditions

    106.Acne Vulgaris

    107.Psoriasis

    108.Atopic Dermatitis

    Section 15:: Hematologic DisordersSection Editor:: Gary C. Yee

    109.Anemias

    110.Coagulation Disorders

    111. Sickle Cell Disease

    112.Drug-Induced Hematologic Disorders

    Section 16:: Infectious DiseasesSection Editor:: Joseph T. DiPiro

    113.Laboratory Tests to Direct Antimicrobial Pharmacotherapy

    114.Antimicrobial Regimen Selection

    115.Central Nervous System Infections

    116.Lower Respiratory Tract Infections

    117.Upper Respiratory Tract Infections

    118.Influenza

    119.Skin and Soft Tissue Infections

    120.Infective Endocarditis

    121.Tuberculosis

    122.Gastrointestinal Infections and Enterotoxigenic Poisonings

    123.Intraabdominal Infections

    124.Parasitic Diseases

    125.Urinary Tract Infections and Prostatitis

    126.Sexually Transmitted Diseases

    127.Bone and Joint Infections

    128.Sepsis and Septic Shock

    129.Superficial Fungal Infections

    130.Invasive Fungal Infections

    131.Infections in Immunocompromised Patients

    132.Antimicrobial Prophylaxis in Surgery

    133.Vaccines, Toxoids, and Other Immunobiologics

    134.Human Immunodeficiency Virus Infection

    Section 17:: Oncologic DisordersSection Editor:: Gary C. Yee

    135.Cancer Treatment and Chemotherapy

    136.Breast Cancer

    137.Lung Cancer

    138.Colorectal Cancer

    139.Prostate Cancer

    140.Lymphomas

    141.Ovarian Cancer

    142.Acute Leukemias

    143.Chronic Leukemias

    144.Multiple Myeloma

    145.Myelodysplastic Syndromes (Web-only)

    146.Skin Cancer

    147. Melanoma

    148. Hematopoietic Stem Cell Transplantation

    Section 18:: Nutritional DisordersSection Editor:: Gary R. Matzke

    149.Assessment of Nutrition Status and Nutrition Requirements

    150.Medication Administration Considerations With Specialized Nutrition Support

    151.Parenteral Nutrition

    152.Enteral Nutrition

    153.Nutritional Considerations in Major Organ Failure

    154.Obesity

    Glossary

    Index

Komentarze (0)